Eutilex Co (XKRX:263050) Construction In Progress : ₩37 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Eutilex Co Construction In Progress?

Eutilex Co's quarterly construction in progress declined from Sep. 2024 (₩239 Mil) to Dec. 2024 (₩37 Mil) but then stayed the same from Dec. 2024 (₩37 Mil) to Mar. 2025 (₩37 Mil).

Eutilex Co's annual construction in progress declined from Dec. 2022 (₩4 Mil) to Dec. 2023 (₩2 Mil) but then increased from Dec. 2023 (₩2 Mil) to Dec. 2024 (₩37 Mil).

Eutilex Co Construction In Progress Historical Data

The historical data trend for Eutilex Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eutilex Co Construction In Progress Chart

Eutilex Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

1,562.88

1,034.23

3.65

1.85

37.45

Eutilex Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Construction In Progress	Get a 7-Day Free Trial															1.85	1.85	238.95	37.45	37.45

Eutilex Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Eutilex Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eutilex Co Ltd (XKRX:263050) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

Daeryung Technotown 17, Suite 1401, Gasan Digital 1-ro 25, Geumcheon-gu, Seoul, KOR, 08594

Website

http://www.eutilex.com

Eutilex Co Ltd is a Korean that operates in the anti-tumor immunotherapy market. The company develops anti-tumor T cell therapy and antibody therapeutics based on its immunotherapy technology. Its pipeline products include T Cell Therapy (4-1BB CTL), CAR-T, and Antibody.

Eutilex Co Headlines

No Headlines